GORI SAVELLINI, GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 5.031
EU - Europa 3.930
AS - Asia 2.174
SA - Sud America 443
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 165
OC - Oceania 4
Totale 11.920
Nazione #
US - Stati Uniti d'America 4.950
RU - Federazione Russa 967
IT - Italia 826
SG - Singapore 679
CN - Cina 609
IE - Irlanda 597
GB - Regno Unito 392
BR - Brasile 363
VN - Vietnam 321
SE - Svezia 235
FR - Francia 217
DE - Germania 209
HK - Hong Kong 194
UA - Ucraina 169
FI - Finlandia 146
KR - Corea 100
ZA - Sudafrica 86
BD - Bangladesh 53
IN - India 53
CA - Canada 38
NL - Olanda 35
PL - Polonia 33
AR - Argentina 31
IQ - Iraq 31
CI - Costa d'Avorio 25
ES - Italia 25
MX - Messico 25
JP - Giappone 24
AT - Austria 17
TR - Turchia 17
NG - Nigeria 16
CZ - Repubblica Ceca 13
PK - Pakistan 13
CO - Colombia 12
EC - Ecuador 12
ID - Indonesia 11
SA - Arabia Saudita 9
BE - Belgio 7
EU - Europa 7
MA - Marocco 7
DZ - Algeria 6
KE - Kenya 6
TN - Tunisia 6
CH - Svizzera 5
CL - Cile 5
EG - Egitto 5
IL - Israele 5
JM - Giamaica 5
PY - Paraguay 5
UY - Uruguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AL - Albania 4
AU - Australia 4
NP - Nepal 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
KZ - Kazakistan 3
LT - Lituania 3
LU - Lussemburgo 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
ET - Etiopia 2
HR - Croazia 2
IM - Isola di Man 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
EE - Estonia 1
GD - Grenada 1
GI - Gibilterra 1
KH - Cambogia 1
Totale 11.748
Città #
Dublin 579
Dallas 497
Ashburn 438
Fairfield 396
Singapore 363
Chandler 303
Moscow 280
Santa Clara 276
Southend 275
Milan 230
Woodbridge 223
San Jose 193
Hong Kong 182
Seattle 180
Wilmington 170
Beijing 165
Siena 162
Cambridge 146
Council Bluffs 144
Houston 140
Jacksonville 131
Hefei 106
Princeton 105
Seoul 98
Ho Chi Minh City 94
Los Angeles 92
Ann Arbor 90
Helsinki 88
Rome 87
New York 76
Johannesburg 73
Hanoi 68
Munich 65
The Dalles 63
Lauterbourg 59
Menlo Park 40
Nanjing 38
São Paulo 38
Fremont 36
Buffalo 35
Florence 35
Warsaw 29
Abidjan 25
Da Nang 25
Boardman 24
Chicago 23
Columbus 23
Orem 23
San Diego 23
Frankfurt am Main 21
Redondo Beach 21
Montreal 20
Atlanta 19
London 19
San Mateo 18
Tokyo 18
Shanghai 17
Abuja 16
Haiphong 16
Dong Ket 14
Nanchang 14
Norwalk 14
Turku 14
Bengaluru 13
Figino 13
Lancaster 13
Lappeenranta 13
Rio de Janeiro 13
Baghdad 11
Chennai 11
Denver 11
Hebei 11
Phoenix 11
Shenyang 11
Tianjin 11
Vienna 11
Brooklyn 10
Düsseldorf 10
Málaga 10
Turin 10
Manchester 9
Nuremberg 9
Poplar 9
Portsmouth 9
San Francisco 9
Venezia 8
Belo Horizonte 7
Biên Hòa 7
Brussels 7
Guangzhou 7
Hải Dương 7
Kunming 7
Mexico City 7
Amsterdam 6
Barnet 6
Charlotte 6
City of London 6
New Delhi 6
North Bergen 6
Olomouc 6
Totale 7.632
Nome #
Diagnostic tools for Toscana virus infection 397
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 386
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 357
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 288
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 285
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 269
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 266
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 251
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 236
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 231
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 230
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus 229
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 227
Identification of a neutralizing epitope on tosv gn glycoprotein 223
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 217
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 213
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 213
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 206
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 205
Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity 203
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector 202
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 201
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 200
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 194
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 193
Development of a mouse model for the study of Toscana virus pathogenesis 192
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 189
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 188
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 187
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 184
Comparative performance of a new sars-cov-2 rapid detection system 182
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases 181
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 179
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 179
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 177
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 176
A novel replication deficient paramyxovirus elicits strong virus neutralising antibody and T cell responses in mice. 173
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 172
How long can SARS-CoV-2 persist in human corpses? 171
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 169
Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication 167
Epidemiology of Toscana virus in South Tuscany over the years 2011-2019 167
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 164
Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system 156
Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein 154
Immunoglobulin M seropositivity for Toscana virus in a random population sample in Sicily 147
SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells 143
Development of a vaccine against hRSV and hPIV3 using a replication deficient Sendai virus vector. 141
Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia 137
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 130
Toscana virus epidemiology: from Italy to beyond. 129
CD40L gene assembled to Immune-Reconstituted Influenza Virosome (IRIV) enhances the immunological and protective activity of a CEA anti-cancer vaccine. 129
Degradation of RIG-I and inhibition of IFN-beta induction by Toscana Virus NSs protein. 126
Development of a vaccine against Toscana Virus. 125
Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability 107
null 103
Seroprevalence and risk factors for Toscana and Sicilian Virus infection in a sample population of Sicily (Italy). 98
null 94
null 94
In vivo study of the PTH-rP DNA/IRIV vaccine for immune response into humanized transgenic mouse. 88
RIG-I-mediated antiviral signalling is inhibited by toscana virus NSs protein. 84
Toscana virus induces IFN-β production by activation of the cellular sensor RIG-I. 80
Prevalence of Toscana and Sicilian phlebovirus antibodies in classic Kaposi’s sarcoma cases and control subjects in Sicily 70
RECOGNITION OF TOSCANA VIRUS NSs REGIONS INVOLVED IN RIG-I DEGRADATION AND IFN-b INHIBITION 67
In vivo study of the PTH-rP DNA/IRIV vaccine for immune response into humanized transgenic mouse. 66
null 41
Molecular Epidemiology of Toscana Virus in Northern and Central Italy Using Metagenomic Next-Generation Sequencing 38
Phenotypic characterization of two neuroinvasive Toscana virus strains clinically associated with self-limited and persistent infections in human neural cells and brain organoids 22
Metagenomic sequencing discloses the virome composition of mosquitoes and sandflies from Central-Southern Tuscany, Italy 20
Molecular evidence of neuroinvasive Sindbis virus infection in humans: detection in cerebrospinal fluid by next generation sequencing 6
Oropouche Virus: Comparative Study of Two Strains Reveals Distinct Innate Immunity Modulation 6
Totale 11.920
Categoria #
all - tutte 40.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022579 0 49 22 30 23 18 32 51 69 55 68 162
2022/20231.036 59 107 135 122 111 224 16 93 100 22 34 13
2023/2024950 29 50 74 73 36 222 341 17 7 12 13 76
2024/20251.933 70 98 177 109 246 129 136 100 210 76 200 382
2025/20264.482 339 576 424 578 830 169 527 136 180 230 158 335
2026/2027462 173 289 0 0 0 0 0 0 0 0 0 0
Totale 11.920